NO173060C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-imino-benzotiazolindrivater og deres fremstilling - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-imino-benzotiazolindrivater og deres fremstilling

Info

Publication number
NO173060C
NO173060C NO895030A NO895030A NO173060C NO 173060 C NO173060 C NO 173060C NO 895030 A NO895030 A NO 895030A NO 895030 A NO895030 A NO 895030A NO 173060 C NO173060 C NO 173060C
Authority
NO
Norway
Prior art keywords
preparation
benzotiazoline
imino
derivatives
therapeutic active
Prior art date
Application number
NO895030A
Other languages
English (en)
Norwegian (no)
Other versions
NO173060B (no
NO895030D0 (no
NO895030L (no
Inventor
Claude Gueremy
Patrick Jimonet
Serge Mignani
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8816546A external-priority patent/FR2640622B1/fr
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO895030D0 publication Critical patent/NO895030D0/no
Publication of NO895030L publication Critical patent/NO895030L/no
Publication of NO173060B publication Critical patent/NO173060B/no
Publication of NO173060C publication Critical patent/NO173060C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO895030A 1988-12-15 1989-12-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-imino-benzotiazolindrivater og deres fremstilling NO173060C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8816546A FR2640622B1 (fr) 1988-12-15 1988-12-15 Derives de l'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
FR898909480A FR2649701B2 (fr) 1988-12-15 1989-07-13 Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant

Publications (4)

Publication Number Publication Date
NO895030D0 NO895030D0 (no) 1989-12-14
NO895030L NO895030L (no) 1990-06-18
NO173060B NO173060B (no) 1993-07-12
NO173060C true NO173060C (no) 1993-10-20

Family

ID=26227049

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895030A NO173060C (no) 1988-12-15 1989-12-14 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-imino-benzotiazolindrivater og deres fremstilling

Country Status (22)

Country Link
US (1) US5008280A (he)
EP (1) EP0374040B1 (he)
JP (1) JPH0733376B2 (he)
AU (1) AU618432B2 (he)
CA (1) CA2005590A1 (he)
CZ (1) CZ280107B6 (he)
DE (1) DE68905585T2 (he)
DK (1) DK169967B1 (he)
ES (1) ES2054068T3 (he)
FI (1) FI93106C (he)
FR (1) FR2649701B2 (he)
GR (1) GR3007788T3 (he)
HU (1) HU203088B (he)
IE (1) IE62714B1 (he)
IL (1) IL92710A (he)
NO (1) NO173060C (he)
NZ (1) NZ231793A (he)
PL (2) PL161336B1 (he)
PT (1) PT92604B (he)
RU (1) RU2037489C1 (he)
SK (1) SK278349B6 (he)
YU (1) YU47337B (he)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US6413948B1 (en) 1996-09-27 2002-07-02 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE102612T1 (de) * 1989-07-13 1994-03-15 Rhone Poulenc Sante 2-imino-3 heterocyclylamino-benzothiazoline, ihre herstellung und sie enthaltende arzneimittel.
US5260297A (en) * 1989-07-13 1993-11-09 Rhone Poulenc Rorer, S.A. 2-imino-3-alkylbenzothiazoline derivatives bearing a heterocyclic substituent on the alkyl group, their preparation and medicinal products containing them.
FR2671081B1 (fr) * 1991-01-02 1994-09-30 Rhone Poulenc Rorer Sa Derives d'imino-2 polyfluoroalkyl-6 heterocyclylalkyl-3 benzothiazoline, leur preparation et les medicaments les contenant.
FR2649702B1 (fr) * 1989-07-13 1991-11-22 Rhone Poulenc Sante Derives d'alkylimino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
US5240948A (en) * 1989-12-13 1993-08-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. 3-(3-alkylthiopropyl)benzothiazoline derivatives, their preparation and the medicament containing them
FR2663029B1 (fr) * 1990-06-07 1992-07-31 Rhone Poulenc Sante Derives de benzothiazole, leur preparation et les medicaments les contenant.
FR2678619B1 (fr) * 1991-07-04 1993-09-17 Rhone Poulenc Rorer Sa Derives de 1,2,4-thiadiazolo[3,4-b]benzothiazole, leur preparation et les medicaments les contenant.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
FR2741804B1 (fr) * 1995-12-01 1998-01-02 Rhone Poulenc Rorer Sa Application de 2-iminobenzothiazolines dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
FR2766487B1 (fr) 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
DE60020556T2 (de) * 1999-05-12 2005-10-27 Neurosearch A/S Ionenkanal modulierende mittel
GB0307067D0 (en) * 2002-12-17 2003-04-30 Aventis Pharma Inc Use of thiazolobenzoheterocycles for treating multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631163B2 (de) * 1976-07-10 1978-06-29 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 2-Iminobenzothiazolen
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
US4918090A (en) * 1988-01-25 1990-04-17 Warner-Lambert Company Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US5985855A (en) 1996-09-27 1999-11-16 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using NAALADase inhibitors
US6004946A (en) 1996-09-27 1999-12-21 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US6413948B1 (en) 1996-09-27 2002-07-02 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors

Also Published As

Publication number Publication date
IE62714B1 (en) 1995-02-22
IL92710A (en) 1993-06-10
FI93106C (fi) 1995-02-27
AU4618989A (en) 1990-06-21
DE68905585D1 (de) 1993-04-29
CA2005590A1 (fr) 1990-06-15
EP0374040B1 (fr) 1993-03-24
US5008280A (en) 1991-04-16
DK633689A (da) 1990-06-16
CZ280107B6 (cs) 1995-10-18
GR3007788T3 (he) 1993-08-31
FI895981A0 (fi) 1989-12-14
PT92604A (pt) 1990-06-29
IL92710A0 (en) 1990-09-17
JPH0733376B2 (ja) 1995-04-12
JPH02223569A (ja) 1990-09-05
NO173060B (no) 1993-07-12
RU2037489C1 (ru) 1995-06-19
DK169967B1 (da) 1995-04-18
NO895030D0 (no) 1989-12-14
NZ231793A (en) 1991-03-26
YU236989A (en) 1991-02-28
ES2054068T3 (es) 1994-08-01
DK633689D0 (da) 1989-12-14
HUT53625A (en) 1990-11-28
PT92604B (pt) 1995-09-12
YU47337B (sh) 1995-01-31
FR2649701B2 (fr) 1991-11-22
CZ708189A3 (en) 1995-06-14
FR2649701A2 (fr) 1991-01-18
EP0374040A1 (fr) 1990-06-20
NO895030L (no) 1990-06-18
DE68905585T2 (de) 1993-09-16
SK708189A3 (en) 1997-01-08
HU896612D0 (en) 1990-02-28
FI93106B (fi) 1994-11-15
PL161369B1 (en) 1993-06-30
IE894006L (en) 1990-06-15
SK278349B6 (en) 1997-01-08
AU618432B2 (en) 1991-12-19
PL161336B1 (pl) 1993-06-30
HU203088B (en) 1991-05-28

Similar Documents

Publication Publication Date Title
NO169439C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler
DK476089D0 (da) Terapeutisk aktive forbindelser og deres fremstilling
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO172048C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazoler
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
NO165398C (no) Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO173060C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-imino-benzotiazolindrivater og deres fremstilling
NO871028D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater.
NO931186L (no) Terapeutisk aktive imidazolderivater, fremgangsmaate for deres fremstilling og anvendelse derav
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO171679C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-(1-piperazinyl)-1h-indazoler
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO891009D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocyklokeptenderivater.
NO170086C (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO923249D0 (no) Terapeutisk aktive pyrimidinderivater og fremgangsmaate for deres fremstilling
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.